FOXO Technologies Inc.

AI Score

XX

Unlock

0.13
0.01 (4.84%)
At close: Apr 02, 2025, 3:59 PM
0.12
-1.33%
Pre-market: Apr 03, 2025, 04:31 AM EDT

Company Description

FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry.

The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey.

It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance.

The company was founded in 2019 and is based in Minneapolis, Minnesota.

FOXO Technologies Inc.
FOXO Technologies Inc. logo
Country United States
IPO Date Sep 16, 2022
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 4
CEO Seamus Lagan

Contact Details

Address:
729 North Washington Avenue
Minneapolis, Minnesota
United States
Website https://www.foxotechnologies.com

Stock Details

Ticker Symbol FOXO
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001812360
CUSIP Number 351471305
ISIN Number US3514713052
Employer ID 85-1050265
SIC Code 6311

Key Executives

Name Position
Seamus Lagan Chief Executive Officer & Director
Martin Christopher Ward FCA Interim Chief Financial Officer

Latest SEC Filings

Date Type Title
Mar 31, 2025 NT 10-K Filing
Mar 24, 2025 D Filing
Mar 21, 2025 D/A [Amend] Filing
Mar 19, 2025 8-K Current Report
Mar 18, 2025 8-K Current Report
Mar 12, 2025 8-K Current Report
Mar 07, 2025 D Filing
Mar 05, 2025 8-K Current Report
Mar 03, 2025 D Filing
Feb 28, 2025 PRE 14C Filing